Strengthening Hope After ICU Discharge

NCT ID: NCT06569901

Last Updated: 2024-09-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

75 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-09-10

Study Completion Date

2030-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to evaluate an interventional program that aims to strengthen hope in intensive care unit (ICU) patients in the rehabilitation phase. The main questions it aims to answer are:

To develop and implement a follow-up service to strengthen hope in ICU patients, and to evaluate the effect on hope in a stepped wedge randomized trial.

To identify possible predictive factors (facilitators and barriers) associated with hope.

Participants will be asked to take part in an ICU follow-up service, a "Hope Intervention" consisting of digital individual- and group conversations. The program will address topics that are important for hope, such as active involvement, social relationships, believes and thoughts of the future.

We will compare the level of hope between participants who have completed the "Hope Intervention" to those that have not yet completed the program.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The ICU patient's situation is challenging as they are acutely ill over a prolonged period of time and receive life sustaining treatment in the ICU.

Having hope and belief in a positive future, even when the prospects of such future are uncertain, may give strength and motivation and possibly improve the outcome in the rehabilitation phase. Hope is scarcely described in ICU patients.

Health care professionals need to learn how to best support ICU patients and promote hope during the rehabilitation period. Therefore, the main aim of the present study is to develop, implement and evaluate a follow up service to former ICU patients to strengthen their hope using a stepped wedge cluster randomized control intervention trial (SW-CRT). The secondary aim is to identify possible predictive factors associated with hope.

The intervention will start after hospital discharge and will be carried out in group sessions.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Critical Care

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

After recruitment of 25 participants, they will be randomized into five clusters. One cluster at a time, will cross over to the intervention group. This recruitment period will be repeated three times to include a total of 75 participants. Prior the intervention, participants will receive "care as usual" and serve as controls.
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cluster A

Cluster A will participate in the Hope Intervention shortly after randomization. Prior the intervention the participants will serve as controls.

Group Type EXPERIMENTAL

Hope Intervention

Intervention Type BEHAVIORAL

Group meetings after hospital discharge reflecting on themes that may have an impact on hope.

The Hope Intervention consists of four group meetings and two individual conversations during a four week period.

Cluster B

Cluster B will participate in the Hope Intervention when Cluster A ends, approximately four weeks after randomization. Prior the intervention the participants will serve as controls.

Group Type EXPERIMENTAL

Hope Intervention

Intervention Type BEHAVIORAL

Group meetings after hospital discharge reflecting on themes that may have an impact on hope.

The Hope Intervention consists of four group meetings and two individual conversations during a four week period.

Cluster C

Cluster C will participate in the Hope Intervention when Cluster B ends, approximately eight weeks after randomization. Prior the intervention the participants will serve as controls.

Group Type EXPERIMENTAL

Hope Intervention

Intervention Type BEHAVIORAL

Group meetings after hospital discharge reflecting on themes that may have an impact on hope.

The Hope Intervention consists of four group meetings and two individual conversations during a four week period.

Cluster D

Cluster D will participate in the Hope Intervention when Cluster C ends, approximately 12 weeks after randomization. Prior the intervention the participants will serve as controls.

Group Type EXPERIMENTAL

Hope Intervention

Intervention Type BEHAVIORAL

Group meetings after hospital discharge reflecting on themes that may have an impact on hope.

The Hope Intervention consists of four group meetings and two individual conversations during a four week period.

Cluster E

Cluster E will participate in the Hope Intervention when Cluster D ends, approximately 16 weeks after randomization. Prior the intervention the participants will serve as controls.

Group Type EXPERIMENTAL

Hope Intervention

Intervention Type BEHAVIORAL

Group meetings after hospital discharge reflecting on themes that may have an impact on hope.

The Hope Intervention consists of four group meetings and two individual conversations during a four week period.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hope Intervention

Group meetings after hospital discharge reflecting on themes that may have an impact on hope.

The Hope Intervention consists of four group meetings and two individual conversations during a four week period.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients ≥18 years
* ICU patient for \> 48 hours
* must be able to communicate verbally just after their ICU stay and be able to handle digital meetings

Exclusion Criteria

* Patients with severe cognitive impairment
* Do not understand and speak Norwegian
* Patients with major psychiatric challenges, suicidal attempts as a reason for ICU stay
* Age over 85 years.
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Vestre Viken Hospital Trust

OTHER

Sponsor Role collaborator

Diakonhjemmet Hospital

OTHER

Sponsor Role collaborator

Oslo University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Tone Rustøen

Reseacher, Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tone Rustøen, PhD

Role: PRINCIPAL_INVESTIGATOR

Oslo University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Vestre Viken HF, Bærum Hospital

Drammen, Akershus, Norway

Site Status NOT_YET_RECRUITING

Diakonhjemmet Hospital

Oslo, , Norway

Site Status NOT_YET_RECRUITING

Oslo University Hospital

Oslo, , Norway

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Norway

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Kristin W Sunde, Msc

Role: CONTACT

+4792095804

Hanne Birgit Alfheim, PhD

Role: CONTACT

+4767509017

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Hanne Birigit Alfheim, PhD

Role: primary

Annikken Hansson

Role: primary

+4722451500

Julie Berntsen, MSc

Role: backup

+4722451500

Kristin W Sunde, MSc

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Herth K. Abbreviated instrument to measure hope: development and psychometric evaluation. J Adv Nurs. 1992 Oct;17(10):1251-9. doi: 10.1111/j.1365-2648.1992.tb01843.x.

Reference Type BACKGROUND
PMID: 1430629 (View on PubMed)

Schneeweiss S, Wang PS, Avorn J, Glynn RJ. Improved comorbidity adjustment for predicting mortality in Medicare populations. Health Serv Res. 2003 Aug;38(4):1103-20. doi: 10.1111/1475-6773.00165.

Reference Type BACKGROUND
PMID: 12968819 (View on PubMed)

Broadbent DE, Cooper PF, FitzGerald P, Parkes KR. The Cognitive Failures Questionnaire (CFQ) and its correlates. Br J Clin Psychol. 1982 Feb;21(1):1-16. doi: 10.1111/j.2044-8260.1982.tb01421.x.

Reference Type BACKGROUND
PMID: 7126941 (View on PubMed)

Russell D, Cutrona CE, Rose J, Yurko K. Social and emotional loneliness: an examination of Weiss's typology of loneliness. J Pers Soc Psychol. 1984 Jun;46(6):1313-21. doi: 10.1037//0022-3514.46.6.1313.

Reference Type BACKGROUND
PMID: 6737214 (View on PubMed)

Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander-Klar H, Kiyasu E, Sobel K, Coyle N, Kemeny N, Norton L, et al. The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer. 1994;30A(9):1326-36. doi: 10.1016/0959-8049(94)90182-1.

Reference Type BACKGROUND
PMID: 7999421 (View on PubMed)

Dufault K, Martocchio BC. Symposium on compassionate care and the dying experience. Hope: its spheres and dimensions. Nurs Clin North Am. 1985 Jun;20(2):379-91.

Reference Type BACKGROUND
PMID: 3846980 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

542348

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

MICU Recovery Clinic
NCT02560129 COMPLETED